Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind placebo-controlled trial of Olevia for primary tinnitus
2015-003514-24Phase 3Completed
- Sponsor
- IBSA Group
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary tinnitus and tinnitus comparing Olevia with Placebo (2 arms). Primary endpoint: Reduction of primary tinnitus severity (THI scale). Started May 2021; status: completed.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
primary tinnitustinnitus
Beyond the preview
Go deeper on 2015-003514-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003514-24.